Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Duavee – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. This report highlights the drug marketed…
R&D services platform will make it easier for researchers throughout the world to purchase InSphero assay ready models and services…
Mechanistic data to be presented at ASH 2019 Annual Meeting Non-IND clinical study initiated to assess safety, tolerability and blood…
DUBLIN–(BUSINESS WIRE)–The “Lupus Nephritis (LN) – Market Insights, Epidemiology and Market Forecast to 2028” drug pipelines has been added to…
Traits added in leading crop with precision gene editing and without integration of foreign genetic material to reduce costs, improve…
WOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–$ABAHF #AbacusHealthProducts–Abacus Health Products, Inc. (CSE:ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that it…
Agreement with Biogen covers Samsung Bioepis’ biosimilar candidates in pre-clinical and clinical development, which reference two widely-used biologic medicines in…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB :ASPCF) will announce its third quarter 2019 financial and operating results on Thursday, November…
Arix Bioscience said Wednesday that its portfolio company Artios Pharma Ltd, has entered in-licensing agreement of a small-molecule ATR inhibitor programme from The University of Texas MD Anderson Cancer Center and ShangPharma.
— Third-Quarter 2019 Net Sales of $335.5 Million Increased 3 Percent; Third-Quarter 2019 GAAP Net Income of $18.2 Million; Adjusted…